Improvement of the quality of life of the patients with atopic dermatitis using the natural cosmetics regimen
Keywords:
atopic dermatitis, natural skincare, skincare regimenAbstract
Dermatitis can provoke depressive symptoms, causing an increased level of anxiety, especially in adolescents, and overall disrupt psychological comfort and balance. Psychogenic factors can exacerbate the disease and consequently reduce the quality of life. Therefore, it is essential to evaluate the impact of the quality of life and symptoms of atopic dermatitis. The study aims to check the effect of the combined skincare regimen of two formulations that have been developed using delicate preservation and lipid regeneration layer system to reduce homeostasis disorders in the form of irritation and/or inflammation on the patients' quality of life with the symptoms of atopic dermatitis. The study results approve the positive effect of the natural regimen for skincare for the patients with atopic dermatitis in connection with the decrease of the burden implied by the disease in both aspects of the visual and sensory effects that negatively impact the quality of life of the patients. This approves the idea that natural skincare regimen reduces the symptoms of atopic dermatitis, positively impacting the psychosocial condition of the patients.
Downloads
References
Egawa G, Kabashima K. Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march. Journal of Allergy and Clinical Immunology. 2016;138(2):350-358.e1.
Wollenberg A, Szepietowski J, Taieb A, Ring J. Corrigendum: Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I. Journal of the European Academy of Dermatology and Venereology. 2019;33(7):1436-1436.
Fishbein A, Silverberg J, Wilson E, Ong P. Update on Atopic Dermatitis: Diagnosis, Severity Assessment, and Treatment Selection. The Journal of Allergy and Clinical Immunology: In Practice. 2020;8(1):91-101.
Hebert A, Stingl G, Ho L, Lynde C, Cappelleri J, Tallman A, Zielinski M, Frajzyngier V, Gerber R. Patient impact and economic burden of mild-to-moderate atopic dermatitis. Current Medical Research and Opinion. 2018;34(12):2177-2185.
Thomsen S. Atopic Dermatitis: Natural History, Diagnosis, and Treatment. ISRN Allergy. 2014;2014:1-7.
Zuberbier T, Orlow S, Paller A, Taïeb A, Allen R, Hernanz-Hermosa J, Ocampo-Candiani J, Cox M, Langeraar J, Simon J. Patient perspectives on the management of atopic dermatitis. Journal of Allergy and Clinical Immunology. 2006;118(1):226-232.
Chang Y, Chiang B. Sleep disorders and atopic dermatitis: A 2-way street?. Journal of Allergy and Clinical Immunology. 2018;142(4):1033-1040.
Pilcher J, Morris D. Sleep and Organizational Behavior: Implications for Workplace Productivity and Safety. Frontiers in Psychology. 2020;11.
Lee S, Shin A. Association of atopic dermatitis with depressive symptoms and suicidal behaviors among adolescents in Korea: the 2013 Korean Youth Risk Behavior Survey. BMC Psychiatry. 2017;17(1).
Na C, Chung J, Simpson E. Quality of Life and Disease Impact of Atopic Dermatitis and Psoriasis on Children and Their Families. Children. 2019;6(12):133.
Augustin M, Radtke M. Quality of life in psoriasis patients. Expert Review of Pharmacoeconomics & Outcomes Research. 2014;14(4):559-568.
Matsuok Y, Yoneda K, Sadahira C, Katssura J, Moriue T, Kubota Y. Effects of skin care and makeup under instructions from dermatologists on the quality of life of female patients with acne vulgaris. The Journal of Dermatology. 2006;33(11):745-752.
Finlay A. Quality of life assessments in dermatology. Seminars in Cutaneous Medicine and Surgery. 1998;17(4):291-296.
Finlay A. Measurement of disease activity and outcome in atopic dermatitis. British Journal of Dermatology. 1996;135(4):509-515.
Salek M, Finlay A, LUSCOMBE D, ALLEN B, BERTH-JONES J, CAMP R, GRAHAM-BROWN R, KHAN G, MARKS R, MOTLEYJ R, ROSS J, SOWDEN J. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial. British Journal of Dermatology. 1993;129(4):422-430.
Herd R, Tidman M, Ruta D, Hunter J. Measurement of quality of life in atopic dermatitis: correlation and validation of two different methods. British Journal of Dermatology. 1997;136(4):502-507.
FINLAY A, KHAN G. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clinical and Experimental Dermatology. 1994;19(3):210-216.
Finlay A. Measures of the effect of adult severe atopic eczema on quality of life. Journal of the European Academy of Dermatology and Venereology. 1996;7(2):149-154.
Nichol M, Margolies J, Lippa E, Rowe M, Quell J. The Application of Multiple Quality-of-Life Instruments in Individuals with Mild-to-Moderate Psoriasis. PharmacoEconomics. 1996;10(6):644-653.
Lewis V, Finlay A. 10 Years Experience of the Dermatology Life Quality Index (DLQI). Journal of Investigative Dermatology Symposium Proceedings. 2004;9(2):169-180.
Zachariae R, Zachariae C, Ibsen H, Mortensen J, Wulf H. Psychological Symptoms and Quality of Life of Dermatology Outpatients and Hospitalized Dermatology Patients. Acta Dermato-Venereologica. 2004;84(3):205-212.
Buske-Kirschbaum A, Geiben A, Hellhammer D. Psychobiological Aspects of Atopic Dermatitis: An Overview. Psychotherapy and Psychosomatics. 2001;70(1):6-16.
Coutanceau C, Stalder J. Analysis of Correlations between Patient-Oriented SCORAD (PO-SCORAD) and Other Assessment Scores of Atopic Dermatitis Severity and Quality of Life. Dermatology. 2014;229(3):248-255.
Ben-Gashir M, Seed P, Hay R. Quality of life and disease severity are correlated in children with atopic dermatitis. British Journal of Dermatology. 2004;150(2):284-290.
Valburg R, Willemsen M, Dirven-Meijer P, Oranje A, Wouden J, Moed H. Quality of Life Measurement and its Relationship to Disease Severity in Children with Atopic Dermatitis in General Practice. Acta Dermato Venereologica. 2011;91(2):147-151.
Koszorú K, Hajdu K, Borza J, Bodai K, Szabó Á, Bató A, Szegedi A, Brodszky V, Rencz F, Sárdy M. 080 The impact of atopic dermatitis on health-related quality of life. Journal of Investigative Dermatology. 2021;141(10):S162.
Catherine Mack Correa M, Nebus J. Management of Patients with Atopic Dermatitis: The Role of Emollient Therapy. Dermatology Research and Practice. 2012;2012:1-15.
Curry E, Warshaw E. Benzyl Alcohol Allergy: Importance of Patch Testing with Personal Products. Dermatitis. 2005;16(4):203-208.
Jacob S, Barron G. Benzyl Alcohol: A Covert Fragrance. Dermatitis. 2007;18(4):232-233.
Schnuch A, Lessmann H, Geier J, Uter W. Contact allergy to preservatives. Analysis of IVDK data 1996-2009. British Journal of Dermatology. 2011;164(6):1316-1325.
Verhulst L, Goossens A. Cosmetic components causing contact urticaria: a review and update. Contact Dermatitis. 2016;75(6):333-344.
Goossens A. New Cosmetic Contact Allergens. Cosmetics. 2015;2(1):22-32.
Herbert V, Spiro J, Reich K, Steinkraus V, Karimi J, Martin V, Breuer K. Glyceryl (mono)caprylate - a new contact allergen. Contact Dermatitis. 2013;69(6):383-385.
Kreeshan F, Williams J. Allergic contact dermatitis to caprylyl glycol: A novel “para‐preservative” allergen. Contact Dermatitis. 2020;83(5):418-419.
Farage M, Mandl C, Berardesca E, I. Maibach H. Sensitive Skin in China. Journal of Cosmetics, Dermatological Sciences and Applications. 2012;02(03):184-195.
Roh N, Han S, Kim M, Park G, Lew B, Choi E, Ko H, Park Y, Son S, Seo Y, Lee Y, Cho S, Park C. Awareness of Atopic Dermatitis and Attitudes toward Different Types of Medical Institutions for Its Treatment among Adult Patients and the Parents of Pediatric Patients: A Survey of 500 Participants. Annals of Dermatology. 2016;28(6):725.
Franki R. Atopic dermatitis hits mental health, quality of life [Internet]. Mdedge.com. 2022 [cited 2022 Mar 15]. Available from: https://www.mdedge.com/psychiatry/article/184217/atopic-dermatitis/atopic-dermatitis-hits-mental-health-quality-life
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
